Login / Signup

Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial.

Raghav SundarNesaretnam Barr KumarakulasingheYiong Huak ChanKazuhiro YoshidaTakaki YoshikawaYohei MiyagiYasushi RinoMunetaka MasudaJia GuanJunichi SakamotoShiro TanakaAngie Lay-Keng TanMichal Marek HoppeAnand D JeyasekharanCedric Chuan Young NgMark De SimoneHeike I GrabschJeeyun LeeTakashi OshimaAkira TsuburayaPatrick Boon-Ooi Tan
Published in: Gut (2021)
UMIN Clinical Trials Registry: C000000082 (SAMIT); ClinicalTrials.gov identifier, 02628951 (South Korean trial).
Keyphrases
  • phase iii
  • clinical trial
  • open label
  • phase ii
  • double blind
  • machine learning
  • placebo controlled
  • study protocol
  • genome wide
  • artificial intelligence
  • big data
  • copy number
  • randomized controlled trial
  • deep learning